New study reveals physical activity in midlife and later life can reduce dementia risk by up to 45%, offering significant ...

Alzheimer’s disease steals memory, independence and, too often, life itself. Drugs can ease symptoms, but none halt the march ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Computer simulations suggest that common plant molecules from Aloe vera might block enzymes tied to Alzheimer’s disease. Scientists have identified potential therapeutic compounds from Aloe vera that ...

Alzheimer’s disease affects many people worldwide, and while it can be diagnosed, many receive the diagnosis too late. Due to ...

A new study finds that taking arginine orally may lower amyloid buildup and neuroinflammation, suggesting a safe, low-cost ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.

Advances in the early treatment of Alzheimer's disease can result in extended years of normal living for patients and caregivers alike.